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Abstract
Major Histocompatibility class II (MHC-II) molecules sample peptides from the extracellular space allowing the immune
system to detect the presence of foreign microbes from this compartment. Prediction of MHC class II ligands is complicated
by the open binding cleft of the MHC class II molecule, allowing binding of peptides extending out of the binding groove.
Furthermore, only a few HLA-DR alleles have been characterized with a sufficient number of peptides (100–200 peptides per
allele) to derive accurate description of their binding motif. Little work has been performed characterizing structural
properties of MHC class II ligands. Here, we perform one such large-scale analysis. A large set of SYFPEITHI MHC class II
ligands covering more than 20 different HLA-DR molecules was analyzed in terms of their secondary structure and surface
exposure characteristics in the context of the native structure of the corresponding source protein. We demonstrated that
MHC class II ligands are significantly more exposed and have significantly more coil content than other peptides in the same
protein with similar predicted binding affinity. We next exploited this observation to derive an improved prediction method
for MHC class II ligands by integrating prediction of MHC- peptide binding with prediction of surface exposure and protein
secondary structure. This combined prediction method was shown to significantly outperform the state-of-the-art MHC
class II peptide binding prediction method when used to identify MHC class II ligands. We also tried to integrate N- and O-
glycosylation in our prediction methods but this additional information was found not to improve prediction performance.
In summary, these findings strongly suggest that local structural properties influence antigen processing and/or the
accessibility of peptides to the MHC class II molecule.
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Introduction
Major histocompatibility complex (MHC) class II molecules
orchestra essential parts of the immune system defining the onset
of for instance cytotoxic T cell induced apoptosis and B cell
proliferation. Identification of which peptides will bind a given
MHC class II molecule is hence of pivotal interest for the
understanding of a host immune response to any given pathogen.
To guide this identification, several prediction methods have been
developed over the last decade (see [1] and references herein).
Prediction of naturally processed MHC class II binding peptides
(MHC class II ligands) is not an easy task. The open binding cleft
for MHC class II molecules allows peptides to extend the nona-
mer binding core. This makes prediction of peptide binding more
challenging for MHC class II compared to MHC class I due to the
need to simultaneous predict the binding register and binding
motif.
Antibodies have been demonstrated to be able to affect antigen
processing either positively or negatively depending upon the
specificity of the antibody and the CD4+T cell [2,3], and the
three-dimensional structure of antigens has been suggested to
influence the processing and presentation of helper T-cell epitopes
[4]. It therefore seems plausible that local structural properties of
the source protein, even though not directly impacting the MHC
class II binding, could impose a differential bias in the likelihood of
a given peptide being processed and presented on the MHC class
II molecule.
In this work, we seek to investigate this assumption and analyze
if properties of peptides defined by the native local structure of the
source protein influence their likelihood of being made available
for binding to MHC class II molecules. The aspect of glycosylation
is also included in the analysis. The vast majority of studies
investigating the effect of glycosylation on T cell recognition is
based on very limited amount of data and is hence highly
anecdotal. Glycosylation of ligands in the MHC-II binding core
region has been found to disfavour MHC class II binding [5].
When present in the binding core, some evidence indicates that
these carbohydrate moieties play an important role in T-cell
recognition [6]. Glycosylations of the flanking amino acids are
found more frequently since these often will allow the T-cell
receptor to get in contact with the MHC:peptide complex [7].
Here, we investigate using a large benchmark data set, whether
ligands are glycosylated or not and if the glycosylation is
overrepresented in MHC class II ligands compared to the
background.
Two large-scale benchmark data sets were used for the analysis
consisting of MHC class II ligands obtained from the SYFPEITHI
database [8]. Native local protein structure properties were
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molecules were predicted using NetMHCIIpan version 1.0 [10], and
N- and O-glycosylation sites were predicted using NetNglyc [11]
and NetOglyc [12]. Using these predicted features, we seek to
analyze if structural properties for MHC class II ligands differ
from other non-ligand peptides with equal binding affinity to the
relevant MHC-II molecule. Demonstrating such a structural
differential bias, we next attempt to combine the local structural
information with the binding strength to the MHC-II molecule in
a model with improved accuracy of prediction for MHC class II
ligands.
Results
Ligands versus non-ligand binders
We first compared the local structural properties of the MHC-II
ligands to that of the corresponding non-ligand peptides. We
define a non-ligand binder as an affinity matched peptide within
the ligand source protein not overlapping with the ligand peptide,
where affinity matched is a predicted binding affinity (in log-
transformed units) in the range 65% of the binding affinity of the
MHC-II ligand. For 87 out of 644 ligands, the criterion (65%) did
not result in any selected peptides because these ligands were
predicted by NetMHCIIpan to be very strong binders, and no other
peptides were found within the source protein with a binding
affinity within the range of -5% of the reference ligand binding
affinity. Requiring that peptides in the non-ligand data set were
found both with stronger and weaker binding affinities compared
to the reference ligand further reduced the set of ligand:non-ligand
binder pairs to 459. When multiple peptides in the source protein
fulfilled the above criteria for non-ligand binder, a random peptide
from the non-ligand pool was selected.
Performing a pairwise comparison of local structural properties
between these 459 ligands and their non-ligand affinity matched
counter-part revealed that MHC class II ligands were significantly
more exposed and had significantly less secondary structure
element (a-helix and b-strand) compared to the non-ligands (see
Table 1). The difference in binding affinity for ligands and non-
ligands was found not significant (p,0.895, paired t-test).
To investigate if this difference in local structural properties
could be contributed to a bias in the NetsurfP method used to
predict the local structural properties, a comparative analysis was
performed using the Real-SPINE 3.0 method for prediction of
residue solvent accessibility [13]. Real-SPINE 3.0 was able to
return residue solvent accessibility predictions for the source-
proteins of 457 of the 459 ligand included in table 1. Using these
predicted exposure values, the mean RSA for the ligand and non-
ligands peptides was found to be 0.214+/2 0.048, and 0.205+/2
0.058, respectively. These values are different from the values
obtained using the NetSurfP method (see table 1). However, the
difference between the two peptides sets is statistically significant
(p,0.05, paired T test). This result thus strongly suggests that the
results obtained in this work are robust and not influenced by the
method applied to obtain local structure predictions, as long as the
method is indeed state-of-the art. Through out the remaining part
of the manuscript only NetSurfP predictions were used.
Training set
To investigate if these findings could be applied to improve the
in silico identification of MHC class II ligands, a simple model was
created which integrated the MHC-II binding affinity with a
structural feature or surface exposure as described by Eq.(1).
x~(1{a):MHCpepza:strucpep, ð1Þ
where x is an MHC class II ligand likelihood score, MHCpep
represents the MHC binding affinity and strucpep is the mean
value of a structural class (i.e. a-helix, b-strand, coil or RSA) for
the peptide. Brute force grid search was used to identify the value
of a that gave the optimal AUC0.1 (see material and methods)
performance measured on the balanced training set.
The average predicted binding affinity for ligands restricted to
different HLA alleles is often very different. For instance is the
average 1-log50k predicted binding value for the ligands in the
training data set restricted to the alleles HLA-DRB1*0101 and
HLA-DRB1*0301 0.4960.19 and 0.1960.14, respectively. This
difference is highly statistically significant (p,0.005, t-test). Even
though these differences are based purely on predicted binding
affinities, the findings correspond to what has been observed for
MHC class I binding, where evidence is merging suggesting that
MHC class I molecules present peptide on the cell surface at
different binding thresholds [14,15]. Thus, to identify an optimal
and HLA universal a-value across all the different HLA-DR
alleles, a re-scaling was made for all predicted binding affinities.
For every allele, the 1-log50k(IC50 nM) binding affinities were
rescaled with a given percentile score. This percentile score was
calculated for each specific allele using a set of 200.000 random
natural 15-mer peptides. The binding affinities were hereby
rescaled according to the percentile chosen. Rescaling at per-
centiles from 1-5 gave very similar results (data not shown). Rescal-
ing was decided to be based on the 1-percentile (Rescaled01) since
this gave a slightly improved performance compared to other
percentile values when evaluated on the balanced training data.
We now use the balanced training data set to define the optimal
value of a for the model defined using Eq. (1). All details of this
calculation are found in Table 2. The AUC0.1 for the raw
NetMHCIIpan method was found to be 0.293. When combined with
relative surface exposure an optimal value of aRSA was found to be
0.30 with an AUC0.1 performance of 0.312. This difference
between the model and the NetMHCIIpan method is highly
statistically significant (p,3.9?10
24). When combining the rescaled
NetMHCIIpan predicted binding affinity with coil predictions an
optimal acoil value was found to be 0.20 with an AUC0.1 value of
0.317.Also,thisincreaseinperformancebetweenthemodelandthe
raw NetMHCIIpan method is statistically significant (p,6.3?10
24).
For the remaining part of the training set, the two models with
aRSA=0.30, and acoil=0.20, respectively, significantly outper-
formed the NetMHCIIpan method (p,10
27,a n dp ,3.5?10
23).
Table 1. Mean and standard deviation value for ligands and
non-ligands compared for the different groups.
Class Ligand Non-ligand P-value
a-helix 0.23160.276 0.28560.322 P,0.002
b-strand 0.28960.207 0.27960.232 P,0.396
a+b 0.52060.171 0.56460.192 P,0.0002
Coil 0.48060.076 0.43760.192 P,0.0002
RSA 0.29860.076 0.27360.099 P,0.0013
1-log50k 0.40460.173 0.40460.173 P,0.895
P-values are obtained from a paired t-test. Class indicates the different classes/
methods used in the analysis. The first groups are self-explanatory (i.e. a-helix,
b-strand, a+b, and coil). RSA is the relative surface accessibility. All these values
are obtained using NetSurfP. 1-log50k is the binding affinity in log-transformed
units obtained from NetMHCIIpan.
doi:10.1371/journal.pone.0015877.t001
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cross validation on the balanced training set was performed. In the
cross-validation 4/5 of the data were applied to estimate the
optimal model parameter a, and the remaining 1/5 of the data
was next used as test set and predicted using this optimal value of
a. This procedure was repeated five times ensuring that all data
points form part of the test set exactly one time. For RSA, the
AUC0.1 value obtained using five-fold cross-validation was 0.309,
and the average optimal a for the 5 cross-validations was
0.33060.045, and similarly was the AUC0.1 value 0.303 for the
model using coil with an average optimal a for the 5 cross-
validations 0.22060.027. These low values on the standard
deviation of the a values indicate that the model is robust and
that is does not suffer from noticeable overfitting.
Next, a model combining MHC binding, RSA and coil was
investigated. The model was defined as described by Eq. (2).
y~Rescale01pepza:coilzb:RSA, ð2Þ
where Rescale01pep is the rescaled binding affinity of the peptide
to the given HLA allele, coil is the average predicted coil score of
the peptide, RSA is the average predicted relative exposure score
of the peptide, and a and b are relative adjustable weights. Brute
force grid search was used again to define weights on RSA and coil
that optimized the AUC0.1 value on the balanced training data.
The best performing model (2) was achieved with a=0.1 and
b=0.5 given an AUC0.1 of 0.351. This value is significantly
higher than the AUC0.1 value of 0.315 obtained by the
NetMHCIIpan (p,2.0?10
29). However, the improvement was not
significant for the model combining RSA and coil compared the
model with RSA alone (p,0.345). This more complex model was
therefore not investigated further.
Test set
Next, the model define by Eq. (1) was investigated using the 697
ligands in the test set. The optimal a-value of 0.30 for RSA was
chosen based on the previous results. The performance measured
by AUC0.1 was increased from 0.318 (NetMHCIIpan) to 0.329
(p,0.018) for MHC binding combined with RSA. For MHC
binding combined with coil, the a-value of 0.20 gave a slight
decrease in the performance from 0.318 to 0.318 (p,0.978). For
details see Table 2.
The model combining MHC affinity with RSA thus consistently
and significantly improved the predictive performance compared
to MHC binding alone on all benchmark data sets, thus
supporting the consistency of the model. In contrast to this, did
the model with coil combined with MHC affinity not improve the
predictive performance above what is obtained using MHC
binding alone when evaluated on the test set.
Glycosylation
The previous analysis demonstrated significant differences in
local structural properties between ligands and affinity matched
non-ligands. Here, we apply a similar approach to investigate if
differences existed between ligands and affinity matched non-
ligands with respect to glycosylation. The comparison between the
459 ligands and non-ligands was used again to identify trends
regarding glycosylation. For all the corresponding source proteins
N- and O-glycosylation were predicted, and the number of
predicted glycosylation within ligands/non-ligands was calculated.
Out of the 459 ligands:non-ligand pairs, 27 ligands were predicted
to be glycosylated. For the non-ligands this number was 50. The
ligands were thus predicted to be significantly (p,0.012, binomial
test) less glycosylated than the non-ligands (see Table 3).
The full training set and test set were also analyzed according to
the glycosylation sites for both N- and O-glycosylation. Out of the
644 ligands in the training set, 6.2% were predicted glycosylated (25
N- and 15 O-glycosylated). Out of the 697 ligands in the test set,
9.6% were predicted glycosylated (36, N- and 31 O-glycosylated).
Table 2. Predictive performance of the model compared to NetMHCIIpan as measured by AUC0.1 and AUC.
RSA NetMHCIIpan Model – Rescaled01
AUC AUC0.1 a AUC AUC0.1 P-value
Balanced training set 0.781 0.293 0.3 0.784 0.312 ,0.0004
Rest of training sset 0.823 0.334 0.3 0.834 0.371 ,10
27
Test set 0.796 0.318 0.3 0.792 0.329 ,0.02
Coil NetMHCIIpan Model – Rescaled01
AUC AUC0.1 a AUC AUC0.1 P-value
Balanced training set 0.781 0.293 0.2 0.782 0.317 ,0.0005
Rest of training set 0.823 0.334 0.2 0.829 0.351 ,0.004
Test set 0.796 0.318 0.2 0.795 0.318 ,0.98
The balanced set was used to identify the optimal weights for RSA and coil combined with rescaled binding affinities (Rescaled01) as define by Eq. (1). The optimal a-
values for each model are given in the table. P-values are given by paired t-tests when comparing AUC0.1 of the model to the NetMHCIIpan method. Rest of training set
refers to the training set, and test to the 697 ligands in the test set.
doi:10.1371/journal.pone.0015877.t002
Table 3. Comparison of glycosylation between ligand and
non-ligands.
Class Ligand Non-ligand P-value
l-log50k 0.40460.173 0.40460.173 ,0.895
N-glyc 20 40 ,0.015
O-glyc 7 10 ,0.63
All the 459 ligands with corresponding non-ligands were analyzed in respect to
N- and O-glycosylation. Ligands and non-ligands were defined as described in
the text. P-values are based on binomial tests, with a hypothesized proportion
of 0.5.
doi:10.1371/journal.pone.0015877.t003
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and O-glycosylated. Taking all peptides within the source proteins
as the background, it was found that the predicted background
frequency for glycosylation for the training set was 9.11% (29654
peptides out of 325276) and for the test set 10.7% (47958 peptides
out of 447453). For both data sets, the background frequency of
glycosylation was thus slightly higher than what was found to the
corresponding ligands, suggesting the MHC class II ligand
presentation could be interfered by glycosylations.
An attempt was made to improve the prediction of MHC class
II ligands combining NetMHCIIpan binding affinity and glycosyl-
ation. Several models were investigated. Even though we showed
above that the ligands are less glycosylated than affinity matched
non-ligands, no model was found that consistently improved the
predictive performance on all three data sets.
Discussion
Characterizing and identifying peptides that bind MHC class II
molecules and elicit an immunogenic response is critical for the
understanding of host-pathogen immune system interactions and
in the selection of candidate peptides in vaccine research. The
process of identifying such peptides is however a highly resource
intensive and difficult task.
During the recent decade several in silico prediction algorithms
have therefore been developed aiming at guiding and cost-
reducing the task of identifying T cell epitopes. While the accuracy
for prediction of MHC class I restricted epitopes/ligands has
reached a level where only few percent of the predictions turn out
to be false [13], the situation for MHC class II is different. Here
the algorithms, even though recently achieving improved predic-
tive performances, maintain a relative low accuracy when it comes
to MHC epitope/ligand discovery [1].
The majority of the methods developed for prediction of MHC
class I restricted ligands and to our knowledge all methods
developed for prediction of MHC class II restricted ligands focus
on prediction of the peptide:MHC binding event alone. The
classical pathway for MHC class II ligand presentation involves
uptake of protein or protein fragments through endocytosis or
phagocytosis by antigen presenting cells (APC). Antibodies can
enhance specific source antigen uptake and presentation to
CD4+T cells by orders of magnitude (reviewed in [16,17,18]).
Once the source antigen has been internalized and processed, one
would a priori expect that any peptide derived from this source
antigen would be offered to MHC class II and could be presented.
However, antibodies have been demonstrated to be able to affect
antigen processing either positively or negatively depending upon
the specificity of the antibody and the CD4+T cell. This T-B cell
reciprocity has been suggested to be the result of antibodies
affecting the outcome of antigen processing in ways that are not
easy to predict. The effect of an antibody that binds to and
protects the bound epitope itself could be to protect the
determinant (enhanced presentation), whereas the effect of an
antibody that binds to and protects a site that needs to be
processed in order to liberate the epitope could lead to inhibition
of processing (reduced presentation). Both effects have been
demonstrated in the literature [2,3].
Since the majority of B cell epitopes are characterized by a
structural signature in that they tend to protrude at the protein
surface and be highly exposed [19,20], we postulated that upon
uptake by the antigen presenting cell, the local structural
properties of an epitope, in the context of the native of the
structure source protein, could impose a differential bias in the
likelihood of a given peptide epitope being appropriately processed
and presented. Moreover has earlier work on antigen processing
and presentation suggested that antigen three-dimensional struc-
ture might influence the processing and presentation of helper T-
cell epitopes [2,3,4].
Here, we further investigated this hypothesis, and analyze to
what extent the local structural properties of an epitope, in the
context of the native structure of the source protein, can impose a
differential bias in the likelihood of a given peptide epitope being
appropriately processed and presented. We investigated this
hypothesis on a large set of MHC class II ligands from the
SYFPEITHI database. Using the state-of-the-art MHC class II
binding predictions, NetMHCIIpan, combined with prediction of
local protein structure by NetSurfP, our analysis revealed that HLA
class II ligands are significantly more exposed and have
significantly less local secondary structure elements compared to
affinity matched non-ligand peptides within the same source
protein. Since the source protein is internalized as a unit and then
processed, our comparison neutralizes the effect upon antigen
uptake, which otherwise would confound the issue of the effect
upon antigen processing. We suggest that our observation could be
the result of antibody-mediated determinant protection and that
this effect dominates over antibody-mediated inhibition of
processing. This interpretation of our results would agree with
recent finding by Sette et al. [21], that in a vaccinia model
demonstrated that CD4+T cells and neutralizing antibodies target
the same protein antigen. Alternatively, the observed structural
bias in MHC ligands could stem from the digestion of the antigen
in the endosomes, since it is possible that surface exposed peptide
fragments are more effectively be released from the antigen
protein structure compared to fragments in the more structurally
stable hydrophobic protein core.
Next, we proposed a method for prediction of MHC ligands
combining MHC class II binding predictions with local
structure prediction, and demonstrated that this method
consistently in three benchmark studies significantly improved
the prediction accuracy of a method based on MHC binding
alone.
It is important to stress that our observations should not be
taken as an indication for MHC class II ligands being absent form
the protein core. Our observations merely demonstrate that a
differential bias exists and that exposed peptide fragments are
more likely presented by MHC class II molecules compared to
affinity matched buried peptides.
We also investigated if glycosylations could have a potential
influence on the likelihood of peptides being presented on MHC
class II molecules, and demonstrated that the MHC class II ligands
are significantly less glycosylated compared to affinity matched
non-ligands. All the ligands used in this work were obtained from
the SYFPEITHI database. The ligand data in this database might
have a certain bias with respect to glycosylation due to the experi-
mental procedure in which they are defined (Stefan Stevanovic,
personal communication). Thus the conclusions regarding glyco-
sylation should be read with some caution.
In conclusion, this work has shown strong evidence that local
structural properties of proteins will significantly bias process-
ing and presentation of the corresponding peptides, and that
highly exposed peptides will have a higher likelihood of being
presented on the cell surface in complex with MHC class II
molecules compared to other affinity matches but less exposed
peptides. We further demonstrate how this finding in a simple
way can be applied to significantly improve the predictions of
MHC class II ligands by combining predicted surface exposure
with state-of-the-art prediction methods for MHC class II
binding.
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Data
The analysis was run on two data sets; a training set and a test
set. The training data set contained 644 unique ligands covering
22 HLA-DR molecules and the test set contained 697 unique
ligands covering 28 HLA-DR molecules. All ligands were obtained
from the SYFPEITHI database [8] and no ligands were common
to both data sets. The source protein for every ligand was searched
in the Uniprot database [22]. If more than one hit existed, the
longest protein was chosen. The two data sets are summarized in
Table 4.
The training set was analyzed thoroughly according to the
distribution of alleles. The allele HLA- DRB1*0401 constituted
more than half of the data set alone - 365 ligands out of 644
ligands. To reduce the allelic bias imposed by the uneven
distribution of ligands per allele in the training set, a balanced
subset of the training set consisting of no more than 30 ligands per
allele was created. This balanced training data set consisted of 290
ligands.
MHC-II ligands and non-ligand MHC-II binding peptides
In the data set of MHC-II ligands, we only have access to
information on which peptides in the given source-protein are
MHC-II ligands. To define a negative set of non-ligand peptide,
we take an approach described earlier in for validation of
prediction methods for both MHC class I and class II (see for
instance [15,23]), and construct the negative set from all other
peptides in the source-protein not equal to a known MHC ligand.
The rational behind this approach is that the MHC molecule is
very specific and will only bind and present a very small fraction of
the source protein peptides [24,25]. Assuming that only one
peptide is presented from each source-protein is clearly an over-
simplification, and it is very likely that some of the non-ligands
might be falsely classified. However, such erroneous classifications
will not invalidate the approach but merely introduce noise
lowering the overall predictive performance of the methods. If we
despite this potential noise observe a significant signal in our
analysis, then the signal would become even stronger in the ideal
(but impossible) situation where also the negative data set was
experimentally validated.
Methods
The source protein was cut into overlapping peptides of a length
equal to the corresponding MHC-II ligand, and the pan-specific
prediction server, NetMHCIIpan version 1.0, which computes the
binding affinity in nM units and reports both this value and a
log50k transformed (i.e. 1-log50k(IC50 nM)) binding value [10],
was applied to predict for each peptide the binding affinity to the
MHC-II molecule in question. Local protein structural features for
each of the source protein peptides were predicted using the
NetSurfP method [9]. This method predicts for each amino acid the
relative surface accessibility (RSA), as well as probabilities the
residue being in an a-helix, b-stand, or coil secondary structure
element. The output from NetSurfP was processed to generate
mean values for the secondary structure elements: a-helix, b-
strand, coil and RSA for each peptide in the source protein. Thus
every peptide was coupled to a predicted MHC class II binding
affinity as well as mean values for a-helix, b-strand, coil and RSA.
The glycosylation sites were predicted with NetNglyc and NetOglyc
with default parameter settings [11,12].
Performance measures
The predictive performance was measured in terms of the area
under the ROC curve (AUC). For each ligand the corresponding
source protein was split into overlapping peptide sequences of the
length of the ligand. All peptides except the annotated HLA ligand
were taken as negatives. This is a very stringent assumption since
for instance suboptimal peptides sharing the ligand binding-core
are counted as negatives even though they could be presented on
the HLA molecule. Thus, this setup is likely to underestimate
the predictive performance, but the effect should be equal for
all methods compared in the benchmark. AUC values were
calculated for each protein-HLA ligand pair and the overall
predictive performance was next measured as the average AUC
value per protein-HLA ligand pair over the data set. Since the
balance between positive and negative peptides in the data sets is
highly skewed with the majority of the peptide being negative, the
AUC measure might not be optimal if a prediction method is
required to have a high specificity in order to lower the false
positive rate for subsequent experimental validation. In such
situations, it is beneficial to use only the high specificity part of the
ROC curve to calculate a fractional AUC value [15]. Here, the
AUC0.1 (AUC integrated up to a specificity of 0.9) value was
used.
Statistical tests
Paired t-tests and binomial tests were used to access differences
between ligands and non-ligands as well as differences between
NetMHCIIpan and the new method. P-values less than 0.05 were
considered statistical significant.
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Table 4. The MHC class II ligands distribution across alleles
for the two data sets.
Allele
Training
set
Test
set Allele
Training
set
Test
set
DRB1*0101 13 47 DRB1*1104 7 2
DRB1*0102 5 1 DRB1*1201 8 6
DRB1*0301 20 89 DRB1*1301 14 12
DRB1*0401 365 154 DRB1*1302 14 9
DRB1*0402 33 4 DRB1*1401 3 7
DRB1*0403 - 1 DRB1*1501 2 21
DRB1*0404 43 4 DRB1*1502 - 3
DRB1*0405 26 10 DRB1*1601 - 2
DRB1*0701 23 27 DRB3*0101 - 3
DRB1*0801 33 7 DRB3*0202 3 -
DRB1*0802 - 1 DRB3*0301 3 2
DRB1*0803 - 1 DRB4*0101 1 5
DRB1*0901 4 2 DRB4*0103 - 2
DRB1*1001 1 241 DRB5*0101 7 14
DRB1*1101 16 20 Total 644 697
doi:10.1371/journal.pone.0015877.t004
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